Indonesia has the largest population in Southeast Asia and a growing pharmaceutical and biotechnology sector. The country's pharmaceutical industry has been expanding its research capabilities, with increasing interest in neurological and neurodegenerative disease research. Several large pharmaceutical companies and emerging biotech firms are developing treatments for CNS disorders.
Large Pharmaceutical Companies
PT Kalbe Farma TBK
Headquarters: Jakarta, Indonesia
Ticker: IDX: KLFA
Website: https://www.kalbefarma.com ...
Overview
Mermaid diagram (expand to render)
Indonesia has the largest population in Southeast Asia and a growing pharmaceutical and biotechnology sector. The country's pharmaceutical industry has been expanding its research capabilities, with increasing interest in neurological and neurodegenerative disease research. Several large pharmaceutical companies and emerging biotech firms are developing treatments for CNS disorders.
Large Pharmaceutical Companies
PT Kalbe Farma TBK
Headquarters: Jakarta, Indonesia
Ticker: IDX: KLFA
Website: https://www.kalbefarma.com
Kalbe Farma is Indonesia's largest pharmaceutical company with diverse therapeutic areas including CNS and neurological disorders. The company has established research partnerships for developing treatments for [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease).
Focus: CNS disorders, Oncology, Vaccines
Pipeline: CNS therapeutic development programs
Approach: In-house R&D, Partnerships
PT Bio Farma (Persero)
Headquarters: Bandung, Indonesia
Website: https://www.biofarma.co.id
Bio Farma is an Indonesian state-owned pharmaceutical company primarily focused on vaccines but has expanded into other therapeutic areas including neurological disorders. The company collaborates with international organizations for research and development.
Focus: Vaccines, Immunology, CNS disorders
Approach: Vaccine and immunotherapy development
PT Kimia Farma TBK
Headquarters: Jakarta, Indonesia
Ticker: IDX: KAEF
Website: https://www.kimiafarma.co.id
Kimia Farma is one of Indonesia's oldest pharmaceutical companies with growing capabilities in CNS drug development. The company has research programs targeting neurodegenerative diseases.
Focus: Generic pharmaceuticals, CNS drugs
Research: Neurodegeneration partnerships
PT Indofarma TBK
Headquarters: Jakarta, Indonesia
Ticker: IDX: INAF
Website: https://www.indofarma.co.id
Indofarma is an Indonesian pharmaceutical company with focus on CNS therapeutics. The company develops generic medications and has interests in neurological disorder treatments.
Focus: CNS disorders, Anti-infectives
Approach: Generic pharmaceuticals
PT Sanbe Farma
Headquarters: Bandung, Indonesia
Website: https://www.sanbefarma.com
Sanbe Farma is a major Indonesian pharmaceutical company with a growing CNS portfolio. The company has established research collaborations for neurodegenerative disease drug development.
Focus: CNS disorders, Metabolic diseases
Pipeline: CNS development programs
PT Dexa Medica
Headquarters: Jakarta, Indonesia
Website: https://www.dexa-medica.com
Dexa Medica is an Indonesian pharmaceutical company focused on CNS and neurological disorders. The company has research partnerships with international institutions for drug discovery.
Focus: CNS disorders, Inflammation
Approach: Drug discovery, Clinical development
PT Ethica Industri Farmasi
Headquarters: Jakarta, Indonesia
Website: https://www.ethica.co.id
Ethica is an Indonesian pharmaceutical company specializing in specialty pharmaceuticals including CNS drugs. The company develops treatments for neurological and neurodegenerative conditions.
Focus: CNS disorders, Specialty pharmaceuticals
Approach: Licensed products, In-house development
Emerging Biotech Companies
Combiphar Labs
Headquarters: Jakarta, Indonesia
Combiphar is an Indonesian pharmaceutical company with growing interest in CNS disorders. The company has research programs targeting neurodegenerative diseases.
Focus: CNS disorders, Consumer health
Approach: Drug development
Phapros TBK
Headquarters: Surabaya, Indonesia
Ticker: IDX: PCAR
Website: https://www.phapros.co.id
Phapros is an Indonesian pharmaceutical company with expanding CNS portfolio. The company develops treatments for neurological disorders.
Focus: CNS disorders, Cardiovascular
Approach: Generic and novel therapeutics
Research Institutions
Eijkman Institute for Molecular Biology
Location: Jakarta, Indonesia
The Eijkman Institute conducts research in molecular biology and genetics relevant to neurodegenerative diseases, with collaborations with pharmaceutical companies.
Universitas Indonesia - Faculty of Medicine
Location: Jakarta, Indonesia
UI has neuroscience research programs with industry partnerships for drug discovery.